Item 8.01 Other Events.

On April 8, 2022, C4 Therapeutics, Inc. (the "Company") issued a press release entitled "C4 Therapeutics Presents Clinical Data from Cohort A of the Ongoing Phase 1/2 Clinical Trial of CFT7455, a Novel IKZF1/3 Degrader." The Company also posted a corporate presentation on CFT7455 AACR Data for its investor webcast on its website at https://ir.c4therapeutics.com/events-presentations. A copy of the press release and the corporate presentation are filed as Exhibits 99.1 and 99.2, respectively, to this Current Report on Form 8-K and are incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit
Number                                    Description
99.1        Press release issued April 8, 2022
99.2        Corporate Presentation of the Company dated April 8, 2022
104       Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses